Are women with osteoporosis treated with denosumab at risk of severe COVID-19?
Anna Maria Formenti, Erika Pedone, Luigi di Filippo, Fabio Massimo Ulivieri, Andrea Giustina
Topics & Concepts
MedicineEpidemiologyDenosumabOsteoporosisCoronavirus disease 2019 (COVID-19)PneumoniaInternal medicineDiseaseInfectious disease (medical specialty)Vitamin D Research StudiesBiomarkers in Disease MechanismsCOVID-19 Clinical Research Studies